SL-1112

N/A

Report date: 2023/05/24 13:30:20

Base Information

Drug NameSL-1112

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionSodium channels blockers

TargetsSodium channels

Therapy Area/IndicationsArrhythmias, Cardiac

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi-Synthelabo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSanofi-Synthelabo

Active IndicationsN/A

Inactive IndicationsArrhythmias, Cardiac

Other Information

ATC CodeN/A

Related LinksN/A